Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
Intravitreal Bevacizumab Therapy for Neovascular Age Related Macular Degeneration Associated with Poor Initial Visual Acuity
British Journal of Ophthalmology, 07/20/09
Galbinur T et al. – Poor initial VA should not refrain from using bevacizumab in eyes with NVAMD. Selection of patients with signs of active neovascularization based on ophthalmoscopy, OCT, and FA may increase the likelihood of favorable response to treatment.
Related Articles
Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration
Retina, 11/11/09
Relevance Score: 68%
Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial
Ophthalmology, 10/28/09
Relevance Score: 68%
siRNA therapeutics for age-related macular degeneration: promises and pitfalls
Expert Review of Ophthalmology, 10/22/09
Relevance Score: 68%
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Relevance Score: 67%
The pathogenic role of the canonical Wnt pathway in age-related macular degeneration
Investigative Ophthalmology and Visual Science, 11/18/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effects of intravitreal bevacizumab (Avastin) therapy on retrobulbar blood flow parameters in patients with neovascular age-related macular degeneration
Journal of Clinical Ultrasound, 12/03/09
N-Acetylcarnosine Lubricant Eyedrops Possess All-In-One Universal Antioxidant Protective Effects of L-Carnosine in Aqueous and Lipid Membrane Environments, Aldehyde Scavenging, and Transglycation Activities Inherent to Cataracts: A Clinical Study of the New Vision-Saving Drug N-Acetylcarnosine Eyedrop Therapy in a Database Population of Over 50,500 Patients
American Journal of Therapeutics, 12/02/09
Photodynamic Therapy With and Without Adjunctive Intravitreal Triamcinolone Acetonide
Ophthalmic Surgery, Lasers and Imaging, 12/01/09
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Pathophysiology and management of diabetic retinopathy
Expert Review of Ophthalmology, 12/07/09
Treatment of branch retinal vein occlusion
Expert Review of Ophthalmology, 12/07/09
Measurement of quality of life for people with diabetic retinopathy impairment
Expert Review of Ophthalmology, 12/07/09
Article Search
Sponsor


See Latest Articles


